[144] Xos, Inc. SEC Filing

Rhea-AI Filing Summary

XOS (Xos, Inc.) Form 144 notice shows a proposed sale of 28,694 shares of common stock through UBS Financial Services with an aggregate market value of $86,082, scheduled approximately for 08/18/2025 on NASDAQ. The shares were acquired by the seller via RSA vesting on 06/23/2025 and payment/issuance occurred the same day. The filing lists past open-market disposals by the same person on 05/27/2025 (1,305 shares) and 05/28/2025 (3,468 shares) with stated gross proceeds. The notice includes the seller's standard representation that they have no undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Officer/insider plans a Rule 144 sale of vested shares; transaction size is small relative to the reported outstanding shares.

The filing discloses a planned Rule 144 disposition of 28,694 vested shares handled by UBS, with an indicated aggregate market value of $86,082 and an approximate sale date of 08/18/2025. The shares were acquired via RSA vesting on 06/23/2025. The document also reports two small prior sales in May 2025. This is a routine insider liquidity event under Rule 144 rather than an operational disclosure. Investors should note timing and broker details for execution transparency.

Corporate Governance Expert

TL;DR: Compliance filing documents an insider sale under Rule 144; contains the standard attestations and broker routing.

The notice includes the required seller attestation about lack of undisclosed material information and provides broker identification (UBS Financial Services). The acquisition source is listed as RSA vesting, with the same-day issuance and no non-cash payment arrangements noted. This meets procedural disclosure expectations for secondary sales by insiders and supports transparency around insider share movements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	28694	86082	8029000	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/23/2025	RSA Vesting	Issuer			28694	06/23/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Luisa Ingargiola 3550 Tyburn Street Los Angeles CA 90065	Common Stock	05/27/2025	1305	4320
Luisa Ingargiola 3550 Tyburn Street Los Angeles CA 90065	Common Stock	05/28/2025	3468	11462

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities are being offered for sale in the XOS Form 144?

The filing reports a proposed sale of 28,694 shares of XOS common stock under Rule 144.

When is the approximate sale date and through which broker will the XOS shares be sold?

The approximate sale date is 08/18/2025 and the broker listed is UBS Financial Services Inc.

How were the shares being sold acquired according to the filing?

The shares were acquired via RSA vesting on 06/23/2025, with the issuance/payment dated the same day.

Does the filing disclose any recent sales by the same person?

Yes. The filing lists prior sales of 1,305 shares on 05/27/2025 and 3,468 shares on 05/28/2025 with gross proceeds shown.

What is the aggregate market value reported for the proposed sale?

The aggregate market value reported for the 28,694 shares is $86,082.